tbuckley/cabot-search huggingface dataset:
Racial and Ethnic Disparities in Childhood Acute Lymphoblastic Leukemia Risk Due to an <i>IKZF1</i> Noncoding Regulatory Variant
Authors: Adam J. de Smith, Lara Wahlster, Soyoung Jeon, Fulong Yu, Susan Black, Steven Gazal, Nicholas Mancuso, Catherine Metayer, Xiaomei Ma, Joseph L. Wiemels, Charleston W.K. Chiang, Vijay G. Sankaran
Journal: Blood (2022)
A Comprehensive DNA Methylome Analysis of Stereotyped and Non-Stereotyped CLL Reveals an Epigenetic Signature with Strong Clinical Impact Encompassing IGHV Status, Stereotypes and IGLV3-21R110
Authors: Martí Duran-Ferrer, Larry Mansouri, Ferran Nadeu, Guillem Clot, Sujata Bhoi, Lesley Ann Sutton, Panagiotis Baliakas, Sara Ek, Venera Kuci Emruli, Karla Plevova, Zadie Davis, Hanna Goransson-Kultima, Anders Isaksson, Karin E. Smedby, Gianluca Gaidano, Anton W. Langerak, Frederic Davi, Davide Rossi, David Oscier, Sarka Pospisilova, Maria Karypidou, Andreas Agathangelidis, Wolfgang Huber, Junyan Lu, Thorsten Zenz, Julio Delgado, Armando Lopez-Guillermo, Paolo Ghia, Elías Campo, Kostas Stamatopoulos, Richard Rosenquist, José I. Martín-Subero
Journal: Blood (2022)
Identification of Robust Predictors for Ibrutinib Response By Multi-Omic Genomics in MYD88 Mutated Waldenstrom's Macroglobulinemia
Authors: Kris Richardson, Jorge J. Castillo, Shayna Sarosiek, Andrew R. Branagan, Catherine A. Flynn, Kirsten Meid, Carly Leventoff, Timothy P White, Megan Little, Joshua Gustine, Xia Liu, Amanda Kofides, Shirong Liu, Alexa Canning, Julie Wolf, Katherine Kacena, Christopher J Patterson, Maria Luisa Guerrera, Nickolas Tsakmaklis, Steven P Treon, Zachary R Hunter
Journal: Blood (2022)
Clonal Hematopoiesis Driven By Recurrent Somatic Mutations but Not with Recurrent Copy Number Alterations Is Associated with Inferior Outcomes in DLBCL after Induction Chemotherapy, but Not CAR19 Therapy
Authors: Jan Boegeholz, Stefan K. Alig, Brian Sworder, Joseph Schroers-Martin, Charles Macaulay, Alexander F.M. Craig, Ulrich Duehrsen, Andreas Hüttmann, Jason Westin, Hua-Jay J. Cherng, David B. Miklos, Matthew J Frank, Maximilian Diehn, David M. Kurtz, Ash A. Alizadeh
Journal: Blood (2022)
Clonal Architecture and Evolution of Waldenström's Macroglobulinemia at the Single Cell Level
Authors: Cristina Jiménez, María García-Álvarez, Miguel Alcoceba, Alejandro Medina, Elham Askari, Veronica Gonzalez-Calle, Maria Casanova, Fernando Escalante Barrigón, M Eugenia Sarasquete, Marcos González Díaz, María Carmen Chillón Santos, Ramón García-Sanz
Journal: Blood (2022)
In Vivo Drug Incorporation and Intracellular Dynamics of Injectable Versus Oral Azacytidine: A Phase II Open Label Multicentre Trial
Authors: John E. Pimanda, Julie A.I. Thoms, Henry R. Hampton, Sarah Davidson, Swapna Joshi, Chowdhury H. Sarowar, Xin Ying Lim, Andrea C. Nunez, Purvi M. Kakadia, Russell Pickford, Mark Raftery, Sally Hough, Griselda Buckland, Michelle Bailey, Yuvaraj Ghodke, Noorul Absar, Lachlin Vaughan, Leonardo Pasalic, Chun Yew Fong, Melita Kenealy, Devendra Hiwase, Rohanna Stoddart, Soma Mohammed, Linda Lee, Freda H. Passam, Kevin Spring, Kristy K. Skarratt, Patricia Rebeiro, Stephen R Larsen, Peter Presgrave, William S Stevenson, Silvia Ling, Campbell Tiley, Stephen Fuller, Fernando Roncolato, Anoop Kumar Enjeti, Dirk Hoenemann, Charlotte Lemech, Stefan K. Bohlander, Jake Olivier, Mark Hertzberg, Ashwin Unnikrishnan, Mark N. Polizzotto
Journal: Blood (2022)
Barriers to Autologous Stem Cell Transplantation As Consolidation for Primary Central Nervous System Lymphoma (PCNSL) in HIV Positive Patients in a Minority Rich Cohort in the Bronx, New York
Authors: Hiba Narvel, Sindhu Vikash, Charan Thej Reddy Vegivinti, Abdul-Hamid Bazarbachi, M Bakri Hammami, Ansh Krishnachandra Mehta, Daniel K. Reef, Adnan Narvel, Riya Patel, Aditi Shastri, Noah Kornblum, Ioannis Mantzaris, Marina Konopleva, Dennis Cooper, Nishi Shah, Mendel Goldfinger, Ira Braunschweig, Amit Verma, R. Alejandro Sica
Journal: Blood (2022)
Synergistic Antitumor Activity of Alnuctamab (ALNUC; BMS-986349; CC-93269), a BCMA 2+1 T Cell Engager (TCE), and Celmod Agents in Multiple Myeloma (MM) Preclinical Models
Authors: Bruno Paiva, Bonny Gaffney, Kelven Burnett, Paola Castiglioni, Michael Angelo, Daniel W. Pierce, Isaac W. Boss
Journal: Blood (2022)
Characterization and T-Cell Repertoire of MB-CART2019.1 (Zamtocabtagene autoleucel) - Data from the Phase I Trial in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Authors: Tatjana Holzer, Stefanie Biedermann, Inga Herfort, Birte Friedrichs, Silke Holtkamp, Linda Hanssens, Mario Assenmacher, Ulf Bethke, Dina Schneider, Stefan Miltenyi, Toon Overstijns, Christoph Schmid, Francis A. Ayuk, Christoph Scheid, Anja Jühling, Udo Holtick, Philipp Gödel, Peter Borchmann, Iris Bürger
Journal: Blood (2022)
Targeting the HSP90-MYC-CDK9 Axis to Overcome Dual Resistance to BTK Inhibition and CAR-T Therapy in Mantle Cell Lymphoma
Authors: Vivian Changying Jiang, Fangfang Yan, Alexa A Jordan, Yuxuan Che, Yang Liu, Qingsong Cai, Yijing Li, Joseph McIntosh, Zhihong Chen, Jovanny Vargas, Yixin Yao, Heng-Huan Lee, Jingling Jin, Wei Wang, Lei Nie, Zhongming Zhao, Lukas M Simon, Michael L. Wang
Journal: Blood (2022)
Identification of Bacterial and Viral Consortia for the Production of Intestinal Microbiota-Derived Metabolites Associated with Protection in Allogeneic Stem Cell Transplantation Patients
Authors: Erik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, Jinling Xue, Paul Heinrich, Sakhila Ghimire, Melanie Tiefgraber, Sophia Göldel, Tina Eismann, Alix Schwarz, Sebastian Jarosch, Katja Steiger, Karin Kleigrewe, Julius Clemens Fischer, Klaus-Peter Janssen, Michael Quante, Simon Heidegger, Peter Herhaus, Mareike Verbeek, Jürgen Ruland, Christian Schulz, Daniela Weber, Matthias Edinger, Daniel Wolff, Dirk Busch, Wolfgang Herr, Florian Bassermann, Li Deng, Andre Gessner, Ernst Holler, Hendrik Poeck
Journal: Blood (2022)
High-Throughput Plasma Proteomic Profiling to Identify Candidate High-Risk Disease Biomarkers in Precursor Multiple Myeloma Patients
Authors: Elizabeth D. Lightbody, Hasmik Keshishian, Habib El-Khoury, Ankit K. Dutta, Hadley Barr, Jes Barbagallo, Namrata Udeshi, Michael P. Agius, Nang Kham Su, Cody J. Boehner, Laura Hevenor, Katherine Towle, Christian J. Cea-Curry, Jacqueline Perry, Erica Horowitz, Maya I. Davis, Anna Cowan, Evan Mills, Marijana Rucevic, DR Mani, Daniel Auclair, Catherine R. Marinac, Michael A Gillette, Steven A Carr, Irene Ghobrial
Journal: Blood (2022)
Hydroxyurea with Dose-Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Tanzania: Primary Results of the Sphere Trial
Authors: Emmanuela E. Ambrose, Teresa Latham, Primrose Songoro, Mwesige Charles, Adam Lane, Susan E. Stuber, Abel Nkono Makubi, Russell E. Ware, Luke R. Smart
Journal: Blood (2022)
Are Pivotal Trials for Drug Approval for Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant Neoplasms Representative of the Population Affected By These Diseases?
Authors: Mahran Shoukier, Monirul Islam, Mycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, Jorge E. Cortes
Journal: Blood (2022)
Trends in Outcomes and Racial Disparities in Adult Hospitalizations for Immune Thrombocytopenia over a Decade
Authors: Rafaella Litvin, Mona Dasgupta, Vaishali Deenadayalan, Ekrem Turk, Khaldun Obeidat, Kriti Ahuja, Shelby D. Rifkin, Hafeez Shaka
Journal: Blood (2022)
Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience
Authors: Aishwarya Sannareddy, Heather Reves, Kefyalew Jaleta, Ramyakumari .Ramiahsankarasubramanian, Hetalkumari Patel, Madhusudhanan Narasimhan, Larry D. Anderson, Aimaz Afrough, Stephen S. Chung, Robert H. Collins, Gurbakhash Kaur, Kiran A Kumar, Yazan F. Madanat, Madhuri Vusirikala, Farrukh T. Awan, Alagarraju Muthukumar, Praveen Ramakrishnan Geethakumari
Journal: Blood (2022)
MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab + Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma
Authors: Elena Zamagni, Mario Boccadoro, Andrew Spencer, Michel Delforge, Donna E. Reece, Agoston Gyula Szabo, Hermann Einsele, Evangelos Terpos, Fredrik Schjesvold, Jelena Bila, Christoph Driessen, Meral Beksac, Gordon Cook, Cesar Rodriguez, Lixia Pei, Yingqi Shi, Caline Sakabedoyan, Jagaoda Jasielec, Himal Amin, Rachel Kobos, Pieter Sonneveld, Niels WCJ Van De Donk
Journal: Blood (2022)
Screening for Acquired Von Willebrand Syndrome in Myelofibrosis - Poor Correlation with Bleeding Risk
Authors: Raphael Costa Bandeira de Melo, Tania Rubia Rocha, Alexandre Eiji Kayano, Guilherme Souza Villar Cassimiro Fonseca, Vanderson Rocha, Wellington F Silva, Fernanda S Seguro
Journal: Blood (2022)
Reticulocytes Are an Unappreciated Risk Factor for RBC Alloimmunization at the Donor and Recipient Levels
Authors: Tiffany Thomas, Annie Qiu, Christopher Y Kim, Dominique E Gordy, Anabel Miller, Maria Tredicine, Elizabeth Stone, Monika Dzieciatkowska, Eldad A. Hod, Angelo D'Alessandro, Steven L Spitalnik, James C Zimring, Imo J Akpan, Chance John Luckey, Krystalyn E Hudson
Journal: Blood (2022)
Phase I/II Study of Azacitidine (AZA) with Venetoclax (VEN) and Magrolimab (Magro) in Patients (pts) with Newly Diagnosed (ND) Older/Unfit or High-Risk Acute Myeloid Leukemia (AML) and Relapsed/Refractory (R/R) AML
Authors: Naval Daver, Jayastu Senapati, Abhishek Maiti, Sanam Loghavi, Tapan M. Kadia, Courtney D. DiNardo, Naveen Pemmaraju, Elias Jabbour, Guillermo Montalban-Bravo, Guilin Tang, Koji Sasaki, Gautam Borthakur, Musa Yilmaz, Joie Alvarez, Sherry A. Pierce, Graciela M. Nogueras González, Jing Ning, Ghayas C. Issa, Michael Andreeff, Hussein A Abbas, Farhad Ravandi, Guillermo Garcia-Manero, Hagop Kantarjian
Journal: Blood (2022)
Immunologic Responses to Sars-Cov-2 Vaccination in Myeloproliferative Neoplasm Patients: Durability, Booster Responses, and Associations with Infections
Authors: Joan How, Kathleen M.E. Gallagher, Yiwen Liu, Katelin Katsis, Eva Elder, Donna S. Neuberg, Patrick M. Reeves, Marcela V. Maus, Gabriela S. Hobbs
Journal: Blood (2022)
Early Hepatotoxicity in Patients with Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
Authors: Marie Robin, Luuk Gras, Nico Gagelmann, Linda Koster, Régis Peffault de Latour, Gwendolyn Van Gorkom, Arnold Ganser, Maija Itälä-Remes, Tsila Zuckerman, Yves Beguin, Nicolaas Schaap, Joanna Drozd-Sokolowska, Kavita Raj, Patrick J Hayden, Liesbeth C. de Wreede, Tomasz Czerw, Juan Carlos Hernandez Boluda, Nicolaus Kröger, Ibrahim Yakoub-agha, Donal P. McLornan
Journal: Blood (2022)
"Gentle Initiation” Rituximab, Lenalidomide and Zanubrutinib Chemo-Free Regimen Followed By Immunochemotherapy for Elderly/Frail Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: An Investigator Initiated, Single Arm, Phase 2 Trial
Authors: Xi Chen, Tao Lei, Haifeng Yu, Cong Li, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood (2022)
Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph + ALL : JALSG Ph+ALL TKI- SCT Study
Authors: Satoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, Yoshihiro Hatta, Noriko Doki, Shingo Kurahashi, Yasunori Ueda, Nobuaki Dobashi, Tomoya Maeda, Yasuhiro Taniguchi, Masatsugu Tanaka, Shinichi Kako, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Atsuta, Shigeki Ohtake, Yuichi Ishikawa, Hitoshi Kiyoi, Itaru Matsumura, Yasushi Miyazaki
Journal: Blood (2022)
Prediction of Outcome in Hospitalized Patients with COVID-19: Development of a COVID-19 Scoring Prognostic Model
Authors: Ganesh Raman, Bilal Ashraf, Yusuf Demir, Corey Kershaw, Sreekanth Cheruku, Murat Atis, Ahsen Atis, Mustafa Atar, Weina Chen, Ibrahim F. Ibrahim, Taha Bat, Mutlu Mete
Journal: Blood (2022)
CPX-351 for Blast-Phase Myeloproliferative Neoplasm (MPN-BP): Mayo Clinic Experience in 10 Consecutive Patients
Authors: Rimal Ilyas, Kristen McCullough, Talha Badar, Mrinal M.M. Patnaik, Hassan B. Alkhateeb, Abhishek A. Mangaonkar, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood (2022)
<i>Ph-like</i> and <i>IKZF1plus</i> Features in Children with Down Syndrome and B Cell Precursor Acute Lymphoblastic Leukemia
Authors: Chiara Palmi, Silvia Bresolin, Stefanie V. Junk, Grazia Fazio, Daniela Silvestri, Marketa Zaliova, Athanasios Oikonomou, Katerina Scharov, Martin Stanulla, Anja Moericke, Martin Zimmermann, Martin Schrappe, Barbara Buldini, Claudia Saitta, Marta Galbiati, Michela Bardini, Sanil Bhatia, Arndt Borkhardt, Luca Lo Nigro, Valentino Conter, Maria Grazia Valsecchi, Andrea Biondi, Geertruij Te Kronnie, Gunnar Cario, Giovanni Cazzaniga
Journal: Blood (2022)
Metallothionein 1 (MT1) Is Selectively Required for <i>DNMT3A;NPM1</i>-Mutant Acute Myeloid Leukemia Proliferation
Authors: Patricia A. Colom Diaz, Chih-Hsing Chou, Jayna J Mistry, Nathan Salomonis, Mohammad Daud Khan, H. Leighton Grimes, Jennifer J Trowbridge
Journal: Blood (2022)
<i>U2AF1</i> Mutant Clonal Hematopoiesis Is Infrequent, Context Dependent, and Commonly Co-Occurs with <i>BCOR</i> Mutations
Authors: Stephanie L. Pritzl, Talha Badar, Alejandro Ferrer, Terra Lasho, Christy Finke, Abhishek A. Mangaonkar, Kristen McCullough, Naseema Gangat, Jenna A. Fernandez, Aref Al-Kali, David S. Viswanatha, Rong He, James M. Foran, Mrinal M. Patnaik
Journal: Blood (2022)
Long Term Follow up of Elderly Patients with Classical Hodgkin's Lymphoma: An Analysis of the Texas Cancer Registry
Authors: Ethan A. Burns, Sunil Mathur, Darshil Choksi, Hala Hassanain, Yuqi Zhang, Cesar Gentille Sanchez, Ryan B. Kieser, Carrie Yuen, Shilpan S. Shah, Siddhartha Ganguly, Sai Ravi Kiran Pingali
Journal: Blood (2022)
High Throughput Pre-Clinical Models to Determine a Synergistic Molar Ratio of 5-Azacitidine to Venetoclax and Uncover Resistance Mechanisms to 5-Azacitidine and Venetoclax Combination Therapy in Acute Myeloid Leukemia
Authors: Mithun Milind Sarangdhar, Eric O'Brien, Brett VanCauwenbergh, Jackson Alexander, Caroline Theile, Mitali Basu, Mayur Sarangdhar, William Seibel, John P Perentesis
Journal: Blood (2022)
Patients Receiving Rasburicase for Treatment and Prophylaxis of Tumor Lysis Syndrome Are Under-Tested for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency: A Single Center Retrospective Analysis
Authors: Rachaita Lakra, Udhayvir Singh Grewal, Lovekirat Dhaliwal, Shiva Jashwanth Gaddam, Samip R. Master, Poornima Ramadas
Journal: Blood (2022)
Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort
Authors: Alexandros Rampotas, Alexandros Rampotas, Grant Vallance, Fotios Panitsas, Nanda Basker, Gina Sangha, Beena Salhan, Farheen Karim, Firas Al-Kaisi, Amy Gudger, Loretta Ngu, Matt Poynton, Ho Pui Jeff Lam, Lowri Morgan, Laura Yang, Jennifer Young, Mairi Walker, Ismini Tsagkaraki, Laura Anderson, Saleena Rani Chauhan, Rebecca Maddams, Richard Soutar, Margarita Triantafillou, Steve Prideaux, Abubaker Obeidalla, Ceri Bygrave, Supratik Basu, Karthik Ramasamy
Journal: Blood (2022)
Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) As Induction Therapy in Patients with Newly Diagnosed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Authors: Patrick K Reville, Hagop Kantarjian, Gautam Borthakur, Musa Yilmaz, Naval Daver, Nicholas Short, Courtney D. DiNardo, Steven M. Kornblau, Naveen Pemmaraju, Nitin Jain, Yesid Alvarado, Prithviraj Bose, Elias Jabbour, Kelly S. Chien, Hussein A Abbas, Lucia Masarova, Sa A Wang, Rebecca S. S Tidwell, Michael Andreeff, Guillermo Garcia-Manero, Marina Konopleva, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2022)
Risk Factors for Thrombosis in Patients Aged &amp;gt; 60 Years with Essential Thrombocythemia without Previous Thrombotic Events
Authors: Roberto Latagliata, Alessandro Andriani, Massimo Breccia, Ida Carmosino, Federico Vozella, Atelda Romano, Annalisa Biagi, Luca Maurillo, Malgorzata Monika Trawinska, Katia Paciaroni, Michelina Santopietro, Sabrina Leonetti Crescenzi, Ada D'Addosio, Caterina Tatarelli, Elisabetta Abruzzese, Ambra Di Veroli, Elena Rossi, Valerio De Stefano, Marco Montanaro
Journal: Blood (2022)
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study
Authors: Giovanni Manfredi Assanto, Alice Di Rocco, Francesco Malfona, Marcello Capriata, Ilaria Del Giudice, Luigi Petrucci, Paola Girardi, Gianna Maria D'elia, Maurizio Martelli, Giuseppe Gentile, Alessandra Micozzi, Alessandro Pulsoni
Journal: Blood (2022)
Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)
Authors: Christopher A. Yasenchak, Rodolfo Bordoni, Dipti Patel-Donnelly, Timothy Larson, Jerome Goldschmidt, Ralph V. Boccia, Vivian J.M. Cline, Adrija Mamidipalli, Jingmin Liu, Joseph T. Beck
Journal: Blood (2022)
Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma
Authors: Paolo Strati, Xubin Li, Qing Deng, Lei Feng, Ryan Sun, Andrew Jallouk, Sherry Adkins, Taylor Cain, Swapna Johncy, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis Fayad, Swaminathan Padmanabhan Iyer, Sandra B. Horowitz, Rachel Nehlsen, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Felipe Samaniego, Maria Alma Rodriguez, Elizabeth J Shpall, Partow Kebriaei, Christopher R. Flowers, David Hong, Jason Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood (2022)
Quality of Life and Symptom Burden of Patients with MPN during Treatment with Hydroxyurea or Pegylated Interferon-alpha2: Results from a Randomized Controlled Trial
Authors: Trine A. Knudsen, Dennis Lund Hansen, Lukas Frans Ocias, Ole Weis Bjerrum, Mette Brabrand, Sarah F. Christensen, Christina Schjellerup S. Eickhardt-Dalbøge, Christina Ellervik, Daniel El Fassi, Mikael Frederiksen, Lasse Kjær, Thomas Kielsgaard Kristensen, Torben A. Kruse, Morten Kranker Larsen, Torben Mourits-Andersen, Ulrik Malthe Overgaard, Marianne Tang Severinsen, Vibe Skov, Anders Lindholm Sørensen, Jesper Stentoft, Jørn Starklint, Karin de Stricker, Mads Thomassen, Thomas S. Larsen, Hans Carl Hasselbalch
Journal: Blood (2022)
Enitociclib (VIP152/formerly BAY1251152) Is a Selective and Active CDK9 Inhibitor : Preliminary Safety and Early Signs of Efficacy in Patients with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Authors: Mazyar Shadman, Anthony R. Mato, Connie Lee Batlevi, Ian W. Flinn, Martin Gutierrez, Marc Uemura, Don A. Stevens, Daniel Morillo, John C. Byrd, Melanie M. Frigault, George Clemens, Xin Huang, Raquel Izumi, Harvey Wong, Renee Breed, Hermes Garban, Amy J. Johnson, Beatrix Stelte-Ludwig, Arushi Mithal, Joseph Birkett, Ahmed Hamdy, Kerry A. Rogers
Journal: Blood (2022)
The ALK-OBS Trial: Results of a Multicenter Prospective Study Assessing the Prognostic Value of New Markers in Adults with ALK-Positive ALCL Treated By CHOEP: A Lysa Study
Authors: David Sibon, Laurence Lamant, Véronique Vergé, Loic Ysebaert, Catherine Thieblemont, Krimo Bouabdallah, Jehan Dupuis, Rémy Gressin, Emmanuel Bachy, Yann Guillermin, Nicolas Daguindau, Charlotte Syrykh, Choquet Sylvain, Pierre Feugier, Caroline Delette, Olivier Casasnovas, Marlene Ochmann, Ronan Le Calloch, Emmanuel Gyan, Herve Tilly, Gandhi Laurent Damaj, Olivier Tournilhac
Journal: Blood (2022)
Clinical and Biological Characteristics and Outcomes of Therapy-Related Acute Lymphoblastic Leukemia (t-ALL) Following Multiple Myeloma Are Distinct in Comparison to t-ALL Following Other Cancers
Authors: Josephine Anne Lucero, Brayan Merchán, Osamah Jamal S. Jarallah, Aniket Bankar, Steven M. Chan, Marta B. Davidson, Vikas Gupta, Dawn Maze, Mark D. Minden, Guillaume Richard-Carpentier, Aaron D. Schimmer, Andre C. Schuh, Karen Yee, Hassan Sibai
Journal: Blood (2022)
Clonal Evolution of Chronic Lymphocytic Leukemia with Bimodal CD49d Expression Reveals CD49d Plasticity
Authors: Erika Tissino, Nicola Calonaci, Federico Pozzo, Gabriela Forestieri, Lodovico Terzi Di Bergamo, Filippo Vit, Annalisa Gaglio, Riccardo Bergamin, Salvatore Milite, Stefano Cozzini, Maria Ilaria Del Principe, Roberta Laureana, Annalisa Chiarenza, Jacopo Olivieri, Francesco Zaja, Cristoforo Fabbris, Valentina Lupato, Riccardo Bomben, Davide Rossi, Valter Gattei, Antonella Zucchetto, Giulio Caravagna
Journal: Blood (2022)
Return Visit Rates after an Emergency Department Treat-and-Release Visit for Children with Sickle Cell Pain Episodes
Authors: Keli C Coleman, Kenneth McKinley, Angela Ellison, Amanda M. Brandow, Blake Nielsen, Lawrence Cook, Elizabeth Alpern, Selena Hariharan, Irina Topoz, Morgan Wurtz, Claudia R. Morris, Andrew D. Campbell, Robert Liem, Rachelle Nuss, Charles T. Quinn, Alexis A. Thompson, Anthony Villella, Ana Baumann, Allison A. King, Warren Frankenberger, David C Brousseau
Journal: Blood (2022)
Hydroxyurea with Dose Escalation to Reduce Primary Stroke Risk in Children with Sickle Cell Anemia in Dominican Republic: The Sacred Trial
Authors: Rosa M. Nieves, Teresa Latham, Nicolle Marte, Luisanna Sanchez, Melissa E. Berges, Gabriela S. Urcuyo, Carla Florencio, Carla Gonzalez, Paola Del Villar, Sheena Chen, Paula Reyes, Daniel Ramirez, Euladys Matos, Manuel Marinez, Susan E. Stuber, William Schultz, Adam Lane, Rafael Mena, Russell E. Ware
Journal: Blood (2022)
Rituximab and Lenalidomide Plus Chidamide Can be an Effective Chemotherapy Regimen for Patients with Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma
Authors: Cong Li, Tao Lei, Haifeng Yu, Xi Chen, Shuiyun Han, Shuailing Peng, Haiyan Yang
Journal: Blood (2022)
Epag 2015 : A Phase II Randomized Placebo-Controlled Study to Assess the Impact on Outcome of Eltrombopag Administered to Elderly Patients with Acute Myeloid Leukemia Receiving Induction Chemotherapy. a French Innovative Leukemia Organization (FILO) Study
Authors: Arnaud Pigneux, Pierre-Yves Dumas, Marc Bernard, Norbert Vey, Audrey Bidet, Ariane Mineur, Mathilde Hunault, Martin Carre, Mario Ojeda, Anne Banos, Pierre Peterlin, Romain Guieze, Yohan Desbrosses, Gabrielle Roth Guepin, Celestine Simand, Thibaut Leguay, Emmanuel Gyan, Eric Jourdan, Jean-Philippe Vial, Tony Marchand, Yosr Hicheri, Marie C Bene, Jean Francois Hamel, Christian Recher
Journal: Blood (2022)
HOXA9 Nucleates a Repressive Chromatin Complex with Nuclear Matrix-Associated Protein- Safb to Maintain Acute Myeloid Leukemia
Authors: Shuchi Agrawal Singh, Jaana Bagri, George Giotopoulos, Eshwar Meduri, Shubha Anad, Sarah J. Horton, Daniel Sasca, Haiyang Yun, Anthony Whetton, Brian James Patrick Huntly
Journal: Blood (2022)
Precision Targeting of MYD88 Mutant DLBCL Using the Novel Combination of Irakimids and BCL2 Inhibition
Authors: Andre M. Grilo, Christine Klaus, Alice McDonald, Jared Gollob, Matt Weiss, Owen A. O'Connor, Gilles Salles, Jayanta Chaudhuri, Jennifer Kimberly Lue
Journal: Blood (2022)
Emicizumab in Management of Hemophilia_A Patients with High Titer FVIII Inhibitor - Real-World Evidence from Poland
Authors: Jerzy Windyga, Joanna Zdziarska, Ewa Stefanska-Windyga, Ewa Chmielewska, Krzysztof Chojnowski, Michal Jamrozik, Aleksandra Kostyra, Justyna Kozinska, Halyna Krainiak, Jolanta Oleksiuk, Joanna Rupa-Matysek, Ewa Zarzycka, Anna Buczma
Journal: Blood (2022)
A Novel Bi-Specific T-Cell Engager Targeting ILT3 Is Potently Effective in Multiple Myeloma
Authors: Francesco Di Meo, Anjushree Iyer, Keith Akama, Christina Yu, Rujin Cheng, Annamaria Cesarano, Silvia Marino, Arafat Aljoufi, Rajesh Soni, Julie M Roda, James Sissons, Ly P Vu, Monica L. Guzman, Kun Huang, David G. Roodman, Fabiana Perna
Journal: Blood (2022)
Duvelisib in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial Expansion Phase: Impact of Prior Treatment and Expanded Safety Analysis
Authors: Eric D Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppe Gritti, Lauren C. Pinter-Brown, Koji Izutsu, Marci Daugherty, Jonathan E Brammer, Neha Mehta-Shah, Barbara Pro, Steven M. Horwitz
Journal: Blood (2022)